Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.31
-0.01-0.76%
At close: -
$1.39
0.086.11%
After Hours: 6:39 PM EDT
Comments
Loading...
GRI Bio Analyst Ratings and Price Targets | NASDAQ:GRI | Benzinga
GRI Bio Inc has a consensus price target of $22 based on the ratings of 2 analysts. The high is $34 issued by Ascendiant Capital on May 27, 2025. The low is $10 issued by HC Wainwright & Co. on June 11, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Ascendiant Capital, and HC Wainwright & Co. on June 11, 2025, May 27, 2025, and April 14, 2025, respectively. With an average price target of $18 between HC Wainwright & Co., Ascendiant Capital, and HC Wainwright & Co., there's an implied 1194.96% upside for GRI Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Ascendiant Capital
1calculated from analyst ratings
Analyst Ratings for GRI Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/11/2025 | Buy Now | 619.42% | HC Wainwright & Co. | Joseph Pantginis46% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/27/2025 | Buy Now | 2346.04% | Ascendiant Capital | Edward Woo75% | $40 → $34 | Maintains | Buy | Get Alert |
| 04/14/2025 | Buy Now | 619.42% | HC Wainwright & Co. | Joseph Pantginis46% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 12/09/2024 | Buy Now | 619.42% | HC Wainwright & Co. | Joseph Pantginis46% | → $10 | Initiates | → Buy | Get Alert |
| 12/05/2024 | Buy Now | 835.25% | Ascendiant Capital | Edward Woo75% | $12 → $13 | Maintains | Buy | Get Alert |
| 10/08/2024 | Buy Now | 763.31% | Ascendiant Capital | Edward Woo75% | → $12 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for GRI Bio (GRI) stock?
The latest price target for GRI Bio (NASDAQ:GRI) was reported by HC Wainwright & Co. on June 11, 2025. The analyst firm set a price target for $10.00 expecting GRI to rise to within 12 months (a possible 619.42% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GRI Bio (GRI)?
The latest analyst rating for GRI Bio (NASDAQ:GRI) was provided by HC Wainwright & Co., and GRI Bio reiterated their buy rating.
When was the last upgrade for GRI Bio (GRI)?
There is no last upgrade for GRI Bio
When was the last downgrade for GRI Bio (GRI)?
There is no last downgrade for GRI Bio.
When is the next analyst rating going to be posted or updated for GRI Bio (GRI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GRI Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GRI Bio was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.
Is the Analyst Rating GRI Bio (GRI) correct?
While ratings are subjective and will change, the latest GRI Bio (GRI) rating was a reiterated with a price target of $10.00 to $10.00. The current price GRI Bio (GRI) is trading at is $1.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
